Chairs: T. Cortes, T. Holyoake, T.P. Hughes
Speakers at this meeting will present the newest and often unpublished data that relate to the biology and management of CML including; signal transduction pathways involved in CML, possible mechanisms of genomic instability, leukemia stem cells and it's relationship to disease kinetics, challenges of monitoring individual patients with hematologic, cytogenetic and molecular methods, role of allogeneic stem cell transplantation in the management of CML, possible role of different immunotherapeutic approaches in CML, treatment-free survival as an endpoint in CML management and patient reported outcomes and their role in the managment of CML patients.
From 15-18 September 2016 more than 370 clinicians and scientists from 33 different countries gathered at the Annual John Goldman Conference on CML in Houston to present the newest and often unpublished data related to the biology and clinical management of CML. ‘John Goldman started this conference as a very small meeting a few years ago that has now evolved into one of the most important meetings for scientists and clinicians interested in CML who take each year a lot of new ideas and inspiration from this meeting', said Jorge Cortes during the opening session. Professor Jorge chaired the meeting together with Professor Tessa Holyoake and Professor Tim Hughes.
It has now become a real tradition at the annual John Goldman Conference on CML. Early Sunday morning at 7 am participants pack their running shoes for the 5k ‘John Goldman Fun Run’ to support the work of the International CML Foundation.
This year 35 meeting participants of the 18th John Goldman Conference on CML in Houston had an early start to the day before the Sunday morning sessions, running a 5km loop round through Houston’s beautiful Memorial Park. Even this early in the morning it was already pretty hot and humid. Whether for recreation, or sporting excellence, it was great fun running together with colleagues and friends all while supporting the work of the Foundation.
From October 1-4, 2015 584 clinicians and researchers from 59 countries gathered for the 17th John Goldman Conference to discuss latest findings in the biology and management of CML.
This conference co-sponsored by the iCMLf and the European School of Haematology is also a great opportunity for the CML community to network and exchange experiences and perspectives: “This premier CML meeting usually offers an exciting CML focused scientific program of high-value, but the most important part of this conference are the discussions with other CML experts united in their effort to develop better treatment and care for patients with CML”, said Jorge Cortes during his opening remarks of the congress. Professor Cortes chaired the meeting together with Professor Tessa Holyoake and Professor Tim Hughes.
On Sunday morning 52 participants of the 17th John Goldman Meeting on CML in Estoril had an early start to the day running with colleagues and friends at the 5 km ‘John Goldman Fun Run’. The atmosphere was breathtaking as the sun rose along the picturesque Estoril promenade. What a start to the day!
Besides the fun and health, it was also for a good cause. A special thank you to those you donated to the iCMLf and received a John Goldman Run T-Shirt. We raised over $1,300 that will go directly to the iCMLf John Goldman Fund to improve CML treatment in the emerging regions.
Here are some impressions from participants of the 2015 ‘John Goldman Fun Run’:
'A wonderful idea to run along the beautiful promenade – what a great experience'
'To run and laugh together brings the CML community even closer together'
'It was really worth getting up so early, and all for a good cause'
From September 4-7, 2014 around 523 key clinicians and researchers from 45 different countries gathered in Philadelphia during the 16th John Goldman Conference on CML to discuss progress in the biology and therapy of CML. The conference, co-sponsored by the iCMLf and the European School of Haematology, again presented latest research findings from both a biological and a scientific perspective: “I was honoured to chair this premier CML meeting and it is amazing to see what we can achieve if clinicians and scientists with a strong CML focus bring together their expertise and jointly discuss their recent research results.” said Professor Jorge Cortes who chaired the meeting together with Professor Tessa Holyoake and Professor Tim Hughes.